Dr. Bruno R. Bastos, MD

Dr. Bastos practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Bastos' NPI, 1619178936, was assigned on May 31, 2007. Dr. Bastos graduated from Federal University of Bahia Faculty of Medicine in 2001. Dr. Bastos holds Florida license ME105209.

Dr. Bastos' primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Bastos' primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Bastos is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Bastos to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bastos practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bastos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bastos is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bastos' licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, lung cancer and prostate cancer among the conditions Dr. Bastos treats.

CMS data shows 842 Medicare services from Dr. Bastos across 7 procedure codes in 2024, for 183 Medicare patients. Medicare paid $46,378 for them.

CMS counts 183 Medicare patients who saw Dr. Bastos in 2024. The largest group is 75 to 84, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bastos' median patient age at 67, with 48% women.

In 2024, Dr. Bastos wrote 217 Medicare Part D claims for 73 patients. 71% of them were for generic drugs. CMS names the drug for 63 of them, across 3 drugs with 11 or more claims each, at $12,460 in total drug cost. In 2023, CMS named 84 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Bastos for performance year 2024, reported through an alternative payment model (APM). Dr. Bastos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bastos as offering telehealth.

Dmand AI links 8 papers to Dr. Bastos, published from 2011 to 2020. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor and Carcinoma, Non-Small-Cell Lung. Dr. Bastos has published most often in Clin Cancer Res. Dr. Bastos' most frequent co-authors are Marcus Otho Butler, MD, Rana Ramzi McKay, MD and Pamela N. Munster, MD.

Dmand AI links Dr. Bastos to 5 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Lymphoid Interstitial Pneumonia. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 544 general payments to Dr. Bastos from 60 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $27,381.

Dmand AI lists 1 award for Dr. Bastos, most recently CMS Stage 1 EHR in 2013.

Dr. Bastos graduated from Federal University of Bahia Faculty of Medicine in 2001. Dr. Bastos is a member of ASCO.

Dr. Bastos is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.